Quick Answer
REPLIGEN CORP reported Diluted EPS of $0.86 per share for fiscal year 2025.
REPLIGEN CORP Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $0.86 | +287.0% |
| 2024 | -$0.46 | -173.0% |
| 2023 | $0.63 | -80.6% |
| 2022 | $3.24 | +44.6% |
| 2021 | $2.24 | +101.8% |
| 2020 | $1.11 | +152.3% |
| 2019 | $0.44 | +18.9% |
| 2018 | $0.37 | -48.6% |
| 2017 | $0.72 | +111.8% |
| 2016 | $0.34 | +21.4% |
| 2015 | $0.28 | +12.0% |
| 2014 | $0.25 | -50.0% |
| 2013 | $0.50 | +11.1% |
| 2012 | $0.45 | — |
| 2011 | $0.00 | +100.0% |
| 2010 | -$0.13 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $0.26 | +2700.0% | +0.0% |
| June 30, 2025 | $0.26 | +160.0% | +160.0% |
| March 31, 2025 | $0.10 | +66.7% | +1100.0% |
| September 30, 2024 | -$0.01 | -103.3% | -110.0% |
| June 30, 2024 | $0.10 | -71.4% | +66.7% |
| March 31, 2024 | $0.06 | -88.2% | -80.0% |
| September 30, 2023 | $0.30 | -57.7% | -14.3% |
| June 30, 2023 | $0.35 | -60.2% | -31.4% |
- REPLIGEN CORP showed an increase of +287.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2010–2025 period, REPLIGEN CORP’s diluted eps has grown by 761.5% (from $0.13 per share (loss) to $0.86 per share).
- The most recent figure is from REPLIGEN CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: